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Background: Resilience or the ability of our body to cope with daily-life challenges has been proposed as a new
definition of health, with restoration of homeostasis as target resultant of various physiological stress responses.
Challenge models may thus be a sensitive measure to study the body’s health. The objective of this study was to
select a dietary challenge model for the assessment of inflammatory resilience. Meals are a challenge to metabolic
homeostasis and are suggested to affect inflammatory pathways, yet data in literature are limited and inconsistent.
Method: The kinetic responses of three different dietary challenges and a water control challenge were assessed
on various metabolic and inflammatory markers in 14 healthy males and females using a full cross-over study
design. The dietary challenges included glucose (75 g glucose in 300 ml water), lipids (200 ml whipping cream) and
a mix of glucose and lipids (same amounts as above), respectively. Blood samples were collected at baseline and at
0.5, 1, 2, 4, 6, 8 and 10 h after consumption of the treatment products. Inflammation (IFNγ, IL-1β, IL-6, IL-8, IL-10,
IL-12p70, TNF-α CRP, ICAM-1, VCAM-1, SAA, E-selectin, P-selectin, thrombomodulin, leukocytes, neutrophils,
lymphocytes) and clinical (e.g. glucose, insulin, triglycerides) markers as well as gene expression in blood cells and
plasma oxylipin profiles were measured.
Results: All three dietary challenges induced changes related to metabolic control such as increases in glucose and
insulin after the glucose challenge and increases in triglycerides after the lipid challenge. In addition, differences
between the challenges were observed for precursor oxylipins and some downstream metabolites including
DiHETrE’s and HODE’s. However, none of the dietary challenges induced an acute inflammatory response, except
for a modest increase in circulating leukocyte numbers after the glucose and mix challenges. Furthermore, subtle,
yet statistically significant increases in vascular inflammatory markers (sICAM-1 and sVCAM-1) were found after the
mix challenge, when compared to the water control challenge.
Conclusions: This study shows that dietary glucose and lipid challenges did not induce a strong acute inflammatory
response in healthy subjects, as quantified by an accurate and broad panel of parameters.
Keywords: OGTT, OLTT, Challenge test, Inflammation, Resilience, Oxylipins, Lipid, Glucose* Correspondence: doris.jacobs@unilever.com
1Unilever R&D, Olivier van Noortlaan 120, Vlaardingen 3130 AC, The
Netherlands
3Netherlands Metabolomics Centre, Einsteinweg 55, 2333 CL, Leiden, The
Netherlands
Full list of author information is available at the end of the article
© 2013 Wopereis et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Wopereis et al. BMC Medical Genomics 2013, 6:44 Page 2 of 16
http://www.biomedcentral.com/1755-8794/6/44Background
The World Health Organization (WHO) defines health as
“a state of complete physical, mental and social well-being
and not merely the absence of disease and infirmity” [1].
Recently, it has been suggested to change the emphasis
of this definition “towards the ability to adapt and self-
manage in the face of social, physical and emotional chal-
lenges” [2].
This concept of resilience links health to the body’s
capacity to deal with daily stressors that challenge our
homeostasis, with restoration of homeostasis as target
resultant of various physiological systems [3]. In order
to comply with this newly proposed definition, experi-
mental models need to be developed that describe the
disturbance and restoration of homeostasis (challenge
models) and that can thus be employed as measures of
health and wellbeing.
This development of challenge models is attractive for
nutritional research increasingly focusing on the mainten-
ance and improvement of health. Nutrition impacts health
every day by inducing subtle and pleiotropic effects that
are not readily detectable using static homeostatic mea-
sures [4]. The kinetic response to a homeostatic perturb-
ation is hypothesized to be a more sensitive measure for
detecting effects of nutritional interventions. Moreover,
comprehensive multi-parametric (“omics”) analysis mea-
sured under conditions of physiological stress may identify
key parameters that are more adequate to describe healthy
and compromised conditions when compared to current
biomarkers, which are typically assessed during steady state
and regarded as markers of disease.
The concept of resilience is relevant for metabolic and
inflammatory processes, because these processes are con-
tinuously challenged and need optimal adaptive flexibility
to maintain optimal health. Metabolic and inflammatory
processes are highly interrelated. Excessive amounts of glu-
cose and lipids induce metabolic stress that is sensed by
metabolic cells such as adipocytes and immune cells such
as macrophages, leading to the induction of oxidative and
inflammatory responses [5,6]. The close functional and
molecular integration of the immune and metabolic sys-
tems is emerging as a crucial homeostatic mechanism, the
dysfunction of which underlies many chronic metabolic
diseases, including type 2 diabetes and atherosclerosis.
The aim of the present study was to investigate the abil-
ity of healthy subjects to restore inflammatory homeostasis
after consumption of high energy dietary loads. Models of
postprandial inflammation were considered as a good start-
ing point to study the inflammatory resilience, considering
the current evidence of inflammatory responses after a
dietary challenge in both healthy and metabolically com-
promised subjects [7-14]. However, data are conflicting.
Derosa et al. have shown that a standardized oral fat load
as well as oral glucose tolerance test (OGTT) inducedsignificant changes in inflammatory response markers and
markers of endothelial dysfunction (hsCRP, IL-6, TNF-α,
sICAM-1, sVCAM-1 and sE-selectin) in adult healthy sub-
jects [15,16]. However, other studies have failed to demon-
strate effects on inflammatory markers (IL-6, TNF-α and
hsCRP) upon a high-fat dietary load in healthy men
[17,18].
Despite the complex regulation of metabolic and in-
flammatory pathways, the postprandial inflammatory re-
sponse to different nutrients have mostly been assessed
using only a limited set of inflammatory markers such as
TNF-α, IL-6 and hsCRP. The response to single bolus
ingestions of glucose and fat have not been compared in
a single study using a broad range of inflammatory me-
diators (cytokines, adhesion molecules, acute phase pro-
teins, haematology, oxylipins) and inflammation related
gene expressions in blood cells.
In this explorative, complete cross-over study, we
compared side-by-side the postprandial inflammatory re-
sponse upon three dietary challenges (glucose, lipids,
mix of glucose and lipids) in healthy subjects using a
multi-parametric analytical approach. We hypothesized
that glucose and lipids will affect different inflammatory
pathways eventually leading to differential gene expres-
sion and levels in inflammatory mediators and that a
mix of glucose and lipids will elicit the strongest inflam-
matory response. A water challenge was included to ac-
count for any diurnal, prolonged fasting or other
experiment-related effects.
Methods
Participants
This study is an exploratory study designed to investigate
the response of many parameters upon different dietary
challenges. As none of these parameters was the clear-cut,
unique endpoint, the sample size was based on a limit for
the desired information increase per additional subject.
This statistical consideration has been outlined by Julious
[19] and resulted in a sample size of 14 subjects per group,
permitting for two possible drop-outs.
Thus, six males and eight females were recruited from
the pool of volunteers of TNO, Zeist. They were appar-
ently healthy adults with the following mean ±SEM
characteristics: age, 54 ± 6 years; BMI, 22 ± 1 kg/m2; and
waist circumference, 80 ± 8 cm. The demographic char-
acteristics of the study participants at inclusion and the
average baseline (t = 0 h) levels of the clinical parame-
ters are listed in Table 1 and Additional file 1: Table S1,
respectively. Exclusion criteria were any history of med-
ical or surgical events, any chronic disease related to in-
flammation or allergy, chronic use of medication that
affect inflammatory processes (e.g. Aspirin, antibiotics),
regular use of lipid lowering medications and/or choles-
terol lowering products (e.g. Becel Pro-activ), lactose
Table 1 Clinical parameters at baseline (t = 0)
OGTT OLTT OL + GTT Control
(n = 14) (n = 14) (n = 14) (n = 14)
Compound Mean std Mean std Mean std Mean std
Glucose [mmol/L] 5.51 0.42 5.46 0.53 5.44 0.61 5.46 0.56
Insuline [mU/L] 4.8 2.3 4.2 1.5 3.8 2.1 3.8 1.5
Cholesterol (total) [mmol/L] 5.44 0.95 5.60 0.98 5.38 1.00 5.38 0.98
HDL cholesterol [mmol/L] 1.63 0.26 1.64 0.31 1.61 0.29 1.65 0.29
LDL cholesterol [mmol/L] 3.3 0.9 3.4 0.9 3.3 0.9 3.2 0.9
Ratio cholesterol/HDL 3.4 0.8 3.5 0.8 3.4 0.8 3.3 0.8
Triacylglycerides [mmol/L] 1.22 0.43 1.16 0.42 1.11 0.49 1.13 0.43
Gamma-GT [U/L] 18.9 9.5 18.5 8.2 17.7 8.6 18.2 8.3
ALAT [U/L] 11 5 11 4 11 6 12 6
ASAT [U/L] 23 9 23 6 27 11 25 10
ALP [U/L] 60 19 59 18 57 17 60 18
Creatinine [μmol/L] 72 10 73 11 73 11 74 11
Urea [mmol/L] 5.4 1.2 5.4 1.0 5.5 1.0 5.8 1.5
RBC [tera/L] 4.59 0.34 4.60 0.31 4.53 0.36 4.60 0.38
Platelets [giga/L] 245 41 248 47 245 44 254 53
Reticulocytes [%] 0.79 0.21 0.77 0.23 0.80 0.27 0.76 0.17
Leucocytes [giga/L] 5.2 1.2 5.0 0.7 4.9 0.9 5.2 0.9
WBC: lymphocytes [%] 35.3 3.7 36.0 6.0 36.3 4.3 36.5 4.2
WBC: neutrophils [%] 54.8 5.8 54.2 7.1 53.6 4.4 53.7 4.7
WBC: monocytes [%] 5.8 1.7 5.9 1.4 6.3 1.5 5.9 1.3
WBC: eosinophils [%] 3.2 1.5 3.2 1.2 3.1 1.1 3.1 1.2
WBC: basophils [%] 0.8 0.3 0.6 0.2 0.7 0.3 0.8 0.2
Total bilirubin [μmol/L] 8.5 3.2 9.7 3.6 8.5 4.6 8.3 3.7
Uric Acid [μmol/L] 262 49 259 52 262 43 263 46
CRP [ng/mL] 736.3 503 634.0 399 918.6 1048 993.1 932
E-selectin [ng/mL] 12.4 3 13.1 3 12.6 4 13.1 4
IFN-gamma [pg/mL] 2.2 2 2.4 3 2.3 3 2.5 3
IL-10 [pg/mL] 198.7 456 187.8 471 188.2 513 211.1 500
IL-12p70 [pg/mL] 336.2 908 269.6 698 335.1 1042 354.1 957
IL-1β [pg/mL] 0.6 1 0.5 1 0.5 1 0.6 1
IL-6 [pg/mL] 1.1 1 1.2 1 1.1 1 1.3 1
IL-8 [pg/mL] 2.2 1 2.6 1 2.4 1 2.5 1
P-selectin [ng/mL] 44.4 16 48.1 14 48.7 19 50.9 20
SAA [ng/mLl] 2117.6 1646 1682.0 795 1924.4 1268 1959.8 1541
TNF-α [pg/mL] 3.6 1 3.8 1 3.9 1 4.2 2
Thrombomodulin [ng/mL] 4.7 1 4.7 1 4.7 1 4.8 1
sICAM-1 [ng/mL] 275.1 34 259.3 38 250.7 43 257.0 41
sICAM-3 [ng/mL] 2.7 1 2.8 2 2.8 1 2.9 1
sVCAM-1 [ng/mL] 442.4 87 440.8 79 419.7 72 448.7 113
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(> 28 units/week for males and > 21 units/week for fe-
males), smoking, extreme physical exercise, reported
slimming or medically prescribed diet, recent blood do-
nation (< 1 month prior to the start of the study), and
for women pregnancy or lactating. The study protocol
was approved by the independent medical ethics com-
mittee of TNO METOPP (Tilburg, The Netherlands)
and all subjects gave written informed consent.
Study design
The subjects were tested on four days separated by one-
week intervals. The total duration of the study was 22 days.
During the whole study period, subjects were asked to main-
tain their habitual diet and normal physical activities. On the
evening prior to each test day, subjects consumed a stan-
dardized meal of ~1000 kcal between 18:00–19:00 h and a
snack between 21:00–22:00 h. After 22:00 h, they were not
allowed to eat. They were only allowed to to drink water.
The subjects were randomly allocated to a study treatment,
with randomization restricted to waist circumference and
age. The challenges were applied according to a Latin square
design [20]. On each test day, the subjects arrived at the re-
search facility in the morning after an overnight fast of
10 hours. A cannula was placed into a vein in the forearm
for collection of blood samples. The cannula was kept patent
by a saline solution infusion over the entire challenge period
of 10 hours. After collection of baseline blood samples (t =
0), subjects consumed one of the challenge test products
within 10 min. Blood samples were collected at regular time
points (0, 0.5, 1, 2, 4, 6, 8, 10 h) up to 10 h. Two time points
(0.5 and 1 h) were sparse sampled (half of the subjects sam-
pled at 0.5 h and the other half at 1 h) to increase the reso-
lution of the population means. No other foods or beverages
were allowed during the day, except water.
Blood samples were collected in tubes containing EDTA
as anti-coagulant. For the gene expression analysis PAX-
gene tubes were used. Whole blood was centrifuged for
10 min at 4°C at 13,000 rpm within 15 min of collection.
Serum and plasma were immediately separated, aliquoted
and stored at −80°C. For the oxylipins an inhibitor cocktail
consisting of butylated hydroxytoluene (BHT), indometh-
acin, paraoxon, 12-[(tricyclo[3.3.1.13,7]dec-1-ylamino)car-
bonyl]amino]-dodecanoic acid and phenylmethylsulfonyl
fluoride [21] was directly added to the plasma samples be-
fore storage.
Dietary challenges
Four challenges were applied. The first challenge test
(OGTT) was 75 g glucose (300 kcal) dissolved in 300 mL
water and thus was identical to the intake used in a stan-
dardized oral glucose tolerance test. The second challenge
test (OLTT) was 200 mL whipping cream (686 kcal; com-
position per 100 mL: 2.3 g proteins, 3.1 g carbohydrates,35.6 g fat) filled up with water to 300 mL. The third chal-
lenge test (OG+ LTT) was 200 mL whipping cream and
75 g glucose filled up with water to 300 mL. The total en-
ergy content of this challenge was 986 kcal. The dietary
challenges were not isocaloric (i) to comply with the stan-
dardized condition of the OGTT challenge test and (ii) to
be in line with other studies typically using >700 kcal for
high-fat dietary challenges [15,17,22,23]. Furthermore, it
was hypothesized that the dietary composition is a more
crucial factor determining the inflammatory response than
the caloric intake. The fourth challenge was a control chal-
lenge consisting of the intake of 300 mL water.
Clinical chemistry and inflammatory marker
measurements
Serum and EDTA-blood were collected for clinical chemis-
try tests and the measurement of a range of inflammatory
markers. Serum clinical chemistry tests included the mea-
surements of γ-glutamyltransferase, alanine aminotrans-
ferase, aspartate aminotransferase, alkaline phosphatase,
glucose, insulin, total bilirubin, creatinine, urea, uric acid,
total cholesterol, HDL cholesterol, LDL cholesterol, triglyc-
erides, CRP, and haematology and were performed using
Olympus analytical equipment and reagents (Olympus
AU400 clinical chemistry analyzer; Olympus-Diagnostica
Europe, Hamburg, Germany). The markers glucose, insu-
lin, total cholesterol, HDL cholesterol, LDL cholesterol,
triglycerides, CRP, total leucocytes and white blood cell dif-
ferentiation parameters were used in the analysis of chal-
lenge test effects. The other clinical chemistry markers
were used for screening of the health status of the study
participants. Plasma samples were used for multi-array
analyses of 7 inflammatory proteins: IFNγ, IL-1β, IL-6, IL-8,
Il-10, Il12p70 and TNF-α (Mesoscale Discovery, Multiplex
panel Human Proinflammatory 7-plex, Rockville, U.S.A.)
and of 8 vascular proteins: CRP, ICAM-1, VCAM-1 and
SAA (Mesoscale Discovery, Multiplex panel Human Vas-
cular Injury II) and sICAM-3, E-Selectin, P-Selectin, and
Thrombomodulin (Mesoscale Discovery, Multiplex panel
Human Vascular Injury I). Most soluble biomarkers dis-
played plasma levels above the lower detection limit of the
assay, except for IL-1β, which was below the lower detec-
tion limit of the assay in most subjects.
Plasma extraction of eicosanoids
Samples from 12 subjects were included in the oxylipin
analysis. The two subjects from the reserve list were ex-
cluded from this analysis. Plasma samples (250 μL) col-
lected at six time points (0, 2, 4, 6, 8, 10 h) for oxylipin
analysis were treated with methanol (1:5) and incubated
for 30 min on ice. Samples were subsequently centrifuged
(5 min at 3000 × g and 4°C) and the supernatant was trans-
ferred to a glass tube. Just before loading on activated
hydrophilic-lypophilic balance (HLB) columns, 4.75 mL of
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were added to the methanol extract, diluting the extract to
20% methanol. After loading, the columns were washed
with 2 mL of 20% methanol in MQ water containing 0.1%
of FA, and the columns were allowed to dry for 15 min.
The solid phase extraction columns were eluted with 2 mL
methanol and the samples were captured in tubes already
containing 20 μL of 10% glycerol and 500 μM BHT in
ethanol. The tubes were placed in a water bath at 40°C.
The methanol was evaporated under a gentle stream of
nitrogen, reconstituted in 100 μL ethanol containing an-
other internal standard 1-cyclohexyl-3-doceanoic acid urea
(CUDA) and immediately used for LC-MS/MS analysis.
LC-MS/MS analysis of eicosanoids
The analysis was performed on a UPLC coupled to a Xevo
TQ-S mass spectrometer (Waters). Five μL extract were
injected on an Acquity C18 BEH UPLC column (2.1 ×
100 mm, 1.7 μm) and separated using gradient elution with
a stable flow of 600 μL/min. The gradient started with 95%
A (MQ water with 0.1% FA) and 5% B (acetonitrile (ACN)
with 0.1% FA) followed by a linear increase to 70% A and
30% B which was achieved at 5.00 min. This was followed
by a linear increase towards 50% A – 50% B which was
achieved at 11.25 min and maintained until 13.25 min. The
system was subsequently switched to 100% B, which was
achieved at 15.75 min and maintained until 16.75 min,
after which the column was equilibrated at 95% A for ap-
proximately 3 min. The column was maintained at 50°C
during analysis, and the samples were kept at 10°C. The
MS was operating in selective reaction mode using electro-
spray ionization in negative ion mode, with a capillary
voltage of 3.3 kV, a source temperature of 150°C and a
desolvation temperature of 600°C. Cone voltage and
collision energy were optimized for each compound indi-
vidually, and parent and product m/z values are listed in
Additional file 1: Table S2. Peak identification and quantifi-
cation were performed using MassLynx software version
4.1. Calibration curves were run in duplicate from which
one regression equation was generated. The calibration
ranges differed, depending on the naturally occurring con-
centrations of the individual compounds in plasma, e.g.
234–15000 μg/L for DHA and 0.12-7.5 μg/L for 15 (S)-
HETE. In order to limit the data processing, only com-
pounds relevant for this study were selected. For this, a lim-
ited number of samples were pooled per time point and
treatment and analyzed as initial batch. Only compounds
detected in this initial batch were selected for further pro-
cessing of the other batches (shown in bold in Additional
file 1: Table S2).
Quality control of LC-MS/MS analysis of eicosanoids
The samples were analyzed in 8 batches. Each batch
contained 42 samples and 6 quality control samplesprepared from a pooled plasma sample. The quality con-
trol samples were used to determine the precision and
accuracy for all compounds reported in this study. The
precision and accuracy were comparable to results pub-
lished by Balvers et al. [21].
Gene expression
Samples from 12 subjects were included in the gene ex-
pression analysis. The two subjects from the reserve list
were excluded from this analysis. Blood samples were
collected in PAXgene tubes (Qiagen/BD) at 0, 2 and 6 h
for each challenge. RNA was isolated using PAXgene
blood RNA kit (Qiagen) according to manufacturer’s in-
structions. Next, 1 μg of RNA was converted into cDNA
using High Capacity RNA-to-cDNA kit (Applied Biosys-
tems) and diluted to 10 ng/μL. Realtime PCR was per-
formed by ServiceXS B.V. (Leiden, the Netherlands) on
Fluidigm’sBioMark 96.96 Dynamic Arrays for Gene Ex-
pression, measuring expression of 96 genes in 96 sam-
ples. The genes were selected based on existing
knowledge of their role in inflammation and based on
expression above background in blood cells based on
previous studies [24,25]. The selected genes included in
the analysis are listed in Additional file 1: Table S3.
The cDNA samples were subjected to 14 cycles of spe-
cific target amplification (STA), using a cocktail of all
combined Gene Expression primer sets and the Taqman-
PreAmp Master Mix (Applied Biosystems). Water was
included as a no-template control (NTC). The NTCs
were also included in the STA reaction, to serve as a
true negative control for the entire procedure. After 5
fold dilution, the STA samples were used on a BioMark
96.96 Dynamic Array for Gene Expression, for determin-
ation of Ct (cycle threshold) values. Pair-wise combina-
tions of all samples were made with each of the assays
on each array. The default EvaGreen PCR protocol was
used on the BioMark instrument with an annealing
temperature of 60°C and a total of 35 cycles of PCR. The
PCR was followed by Melting Curve Analysis. Melting
was monitored between 60 and 95°C.
The BioMark Real-Time PCR Analysis software ver-
sion 3.0.2 was used for Ct determination from the 9216
reaction chambers on each array and for the analysis of
melting curve data (default settings). The baseline cor-
rection chosen was ‘Linear’ in combination with the
‘User (Detectors)’ Ct threshold method, using the option
‘Initialize with Auto’.
For each gene, a dilution series was measured using a
pooled sample. This dilution series was used to assess
the relative concentrations of each gene which were then
corrected for the relative concentration of housekeeping
gene ubiquitin C (UBC). Eight genes did not pass quality
control: CCL20, CXCL2, CYP4A11, MRC1, PTGIS,
EMP1, AKR1C3, and NOS2. Furthermore, two
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were included on the array but not considered for fur-
ther analysis because of the better performance of the
housekeeping gene UBC. Thus, a total of 85 genes were
quantified and used to assess the effect of the different
challenges. They were analyzed in Ingenuity (Ingenuity
Systems Inc, Redwood City, CA, USA) and enriched in
biological functions related to inflammatory response
(#72 out of 85 genes), cellular movement (#65 out of 85
genes) and immune cell trafficking (#63 out of 85 genes).
Based on top networks, and canonical pathways different
gene-sets were created related to specialized biological
functions and pathways: lipid metabolism related to in-
flammatory response (n = 14); inflammatory response
related to infectious disease (n = 11); lipid metabolism
related to molecular transport (n = 11); organ develop-
ment and lymphoid tissue (n = 11); antigen presentation
and cellular movement (n = 10); IL-10 signaling (n =
17); atherosclerosis signaling (n = 18); peroxisome
proliferator-activated receptor (PPAR) signaling (n = 15)
and IL-6 signaling (n = 15). The genes belonging to
these different gene-sets are summarized in Additional
file 1: Table S4.
Data analysis
The kinetic response of the four different dietary chal-
lenges on various metabolic and inflammatory markers
was assessed by determining delta values relative to
baseline concentrations and by several area under the
curve (AUC) measures calculated by the trapezoidal rule.
First, the AUC and incremental AUC (iAUC) values cor-
rected for the baseline measurement (t = 0) were calcu-
lated. Secondly, the iAUC under (AUCmin) and over
(AUCplus) the baseline measurement (t = 0) as well as
their sum (AUCtotal) were calculated. A mixed model
analysis was used to test for differences in AUC between
the dietary challenges and the water control challenge
(Additional file 1: Figure S1) with challenge, visit and co-
hort as fixed factors, baseline and baseline*challenge as
covariates and the subjects as random factor, where the *
refers to an interaction effect. Next, the challenge re-
sponse curves of the different markers were compared
by a repeated-measures analysis with challenge, visit, co-
hort, time, challenge*time, visit*time and challenge*time
as fixed factors, baseline, baseline*challenge and baseli-
ne*time as covariates and the subjects as random factor,
where the * refers to an interaction effect. For both ana-
lyses, the challenges were compared to the water control
challenge using a 2-sided test adjusted by a Dunnett
multi-comparison correction. The null hypothesis (no
difference) was rejected when the p-value was below
0.05. If necessary, AUC and response curve data were
log-transformed. For this, the Anderson-Darling test was
used to test for normality; a log transformation wasapplied when the data were not normal. Statistical out-
liers, defined as a value that differed more than 3 times
the standard deviation from the median value, were ex-
cluded for analysis. When visualizing average curves of
treatments the outliers were replaced by the median
response value of the corresponding individual. Data
visualization of the individual and average response
curves of each marker was performed using Tibco Spot-
fire 2.2 0 (Tibco Spotfire Inc., Somerville, MA, USA).
All statistical analyses were performed using SAS 9.2
(SAS Institute Inc. Cary, NC, USA).Results
Baseline characteristics of study population
Clinical chemistry
All subjects met our inclusion criteria. The demographic
data and baseline (t = 0) clinical chemistry characteristics
of the 14 subjects who participated in the study are given
in Table 1 and Additional file 1: Table S1, respectively. No
differences between baseline values were found between
the different challenges. One subject had high fasting glu-
cose levels (ranging between 5.9 and 6.5 mmol/L; normal
values < 6.1 mmol/L) and two other subjects had high
levels of total cholesterol (ranging from 6.2-7.2 and 6.9-
7.4 mmol/L, respectively. Values > 6.2 mmol/L were con-
sidered as high risk).Inflammatory markers
To assess the inflammatory response, a series of plasma
markers i.e. CRP, SAA, sVCAM-1, sICAM-1, sICAM-3,
IL-1β, IL-6, IL-8. IL − 10, IL-12p70, IFNγ, TNF-α, E-
Selectin, P-Selectin, and thrombomodulin were mea-
sured. In addition, total leukocyte counts in plasma as
well as lymphocytes, neutrophils, monocytes, eosinophils
and basophils in white blood cells (WBC) were mea-
sured. The average baseline values and standard devia-
tions for these markers are summarized in Table 1. The
average baseline levels of cytokines, vascular adhesion
molecules, SAA and CRP were not significantly different
between the challenges, except for the baseline levels of
IFNγ and TNF- α which were significantly lower prior
to the OL +GTT and OGTT challenges, respectively,
when compared to the control challenge.
All subjects had normal values of the inflammatory
marker CRP ( i.e. < 10 mg/L) and the white blood cell
counts (i.e. < 11 × 10E9/L). Therefore, we concluded that
these subjects had no clinical inflammation. IL-10 and
IL-12 showed the largest individual variation. Four out
of 14 subjects had i.e. 1–2 orders of magnitude higher
plasma concentrations of these cytokines. These high
levels were consistently observed for the same subjects
throughout the study. These 4 subjects also consistently
displayed the highest levels of IFNγ, IL-1β, and TNF-α.
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Oxylipins and gene expression
No baseline differences were observed for oxylipins and
most genes measured. The expression of the genes
LCN2 (p = 0.050) and MAPK1 (p = 0.040) were margin-
ally higher at OLTT baseline and the expression of
PPARG was significantly (p = 0.0098) lower at OGTT
baseline (1.7 fold difference from the control value).
Effect of dietary challenges
Clinical chemistry
The effect of different dietary challenges on a few clinical
parameters (glucose, insulin, total cholesterol, HDL choles-
terol, LDL cholesterol, and triglycerides) was investigatedTime (h)
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Figure 1 Effect on glucose, insulin and triglycerides. Mean ± SEM postp
(N = 14) after ingestion of water (□), OGTT (◊), OLTT (△), OG + LTT (○). ANOVA
orange p < 0.001; water versus baseline; * p < 0.05, ** p < 0.01, *** p < 0.001.to check whether the challenges were successful. As ex-
pected the control challenge resulted in significantly de-
creased concentrations of most clinical chemistry
parameters, when compared to baseline. Especially glucose
(from 5.46 to 4.84 mmol/L), insulin (from 3.8 to 0.9 mU/L),
and triglycerides (from 1.13 to 0.87 mmol/L) showed a
strong linear decrease in plasma concentrations with lowest
concentrations at 10 h due to up to 20 h of fasting
(Figure 1).
The metabolic markers responded to the dietary chal-
lenges as expected: the glucose intake (OGTT) induced
significantly different responses of plasma glucose and
insulin when compared to the control challenge. Glu-
cose concentrations increased at time points 0.5 h
(8.26 mmol/L for OGTT vs 5.08 mmol/L for control)
and 1 h (7.96 mmol/L for OGTT vs 5.45 mmol/L forTime (h)
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randial relative glucose, insulin and triglycerides in healthy subjects
: OGTT, OLTT, OL + GTT versus water: green p < 0.05, yellow p < 0.01,
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lin showed increased concentrations at 0.5 h (34.6 mU/L
for OGTT vs 2.3 mU/L for control), 1 h (27.7 mU/L for
OGTT vs 2.6 mU/L for control) and 2 h (15.2 mU/L for
OGTT vs 2.6 mU/L for control) (Figure 1).
Due to the lipid load (OLTT) the plasma insulin and
triglyceride response was significantly different from the
control curve (Figure 1). Insulin showed significantly
higher concentrations at 0.5 h up to 4 h compared to
control (9.4; 6.2; 4.3; and 3.4 mU/L for OLTT vs 2.3; 2.6;
2.6; and 1.6 mU/L for control). Triglycerides showed sig-
nificant higher concentrations 2 h up to 6 h compared
to control (1.73; 2.06; and 1.59 mmol/L for OLTT vs
1.04; 1.03 and 0.93 mmol/L for control) and baseline.
The combined lipid and glucose load (OG + LTT) in-
duced significantly different responses of plasma insulin,
glucose, and triglycerides when compared to the control
challenge (Figure 1). Insulin showed significant higher
concentrations at 1–4 h and 8 h (25.8; 19.0; 7.6 and
1.6 mU/L for OG + LTT vs 2.6; 2.6; 1.5 and 1.2 mU/L for
control), and glucose had significant higher concentra-
tions at 1–2 h and 8–10 h compared to control (7.09;
6.28; 5.12 and 5.12 mmol/L for OG + LTT vs 5.45; 5.32;
4.94 and 4.84 mmol/L for control). Triglycerides showed
significantly higher concentrations at 2–6 h andTime (h)
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Figure 2 Effect on leucocytes, lymphocytes and neutrophils. Mean ± S
in healthy subjects (N = 14) after ingestion of water (□), OGTT (◊), OLTT (△)
p < 0.05, yellow p < 0.01, orange p < 0.001; water versus baseline; * p < 0.significantly lower concentrations at 10 h (1.54; 1.56;
1.55 and 0.73 mmol/L for OG + LTT vs 1.03; 0.93; 0.92
and 0.87 mmol/L for control).
Inflammatory markers
Changes in leukocytes were observed upon all dietary chal-
lenges and the water control challenge. Total leukocytes
displayed an increase in number over time, but stayed
within normal clinical reference ranges (i.e. <11 × 109/L).
Statistically significant increases compared to baseline oc-
curred at 2 h and 10 h after the control challenge, at 2, 4,
6, 8 and 10 h after both OLTT and OG+ LTT, and at 6, 8
and 10 h after OGTT (Figure 2). Between-challenge com-
parisons showed that the increases in leukocyte numbers
were significantly different from the control challenge at
6 h after the OGTT challenge (6,5 × 109/L for OGTT vs
5.6 × 109/L for control, p < 0.01) and at 6 h (6.1 × 109/L
for OG+ LTT vs 5.6 × 109/L for control, p < 0.05), 8 h
(6.2 × 109/L for OG+ LTT vs 5.6 × 109/L for control, p <
0.01) and at 10 h (6.3 × 109/L for OG+ LTT vs 5.9 × 109/L
for control, p < 0.05) after the OG+ LTTchallenge. No sig-
nificant differences from the control challenge were found
for the leukocyte numbers after the OLTTchallenge.
An initial increase of % neutrophils was observed with
statistically significant differences from baseline withinTime (h)
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05, ** p < 0.01, *** p < 0.001.
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water control challenge (Figure 2). The percentage of
neutrophils then gradually declined over time, with the
exception of a second peak appearing at 6 h after the
OGTT challenge, which was statistically different from
baseline, and from the control challenge (62% for OGTT
vs 54% for control, p < 0.01). Neutrophil levels in the
other groups were not different from the levels after the
water control challenge.
In contrast, the percentage of lymphocytes significantly
decreased during the first 2 hours after the dietary and
water control challenges compared to baseline (Figure 2).
The percentage then gradually increased in all groups.
Only after the OGTT challenge a second decrease was ob-
served at 6 h, which was statistically different from base-
line, and from the control challenge (31% for OGTT vs
38% for control, p < 0.01) thus mirroring the effect ob-
served in the neutrophil population.
Compared to baseline, small statistically significant
changes were observed at a few time points in the water
control group (i.e. decreases in CRP, IL-8, SAA, TNF-α,
sICAM-1, sVCAM-1, E-selectin, P-selectin, thrombomo-
dulin, and increase in IL-6) after OGTT (i.e. decreases
in CRP, IL-8, SAA, sICAM-1, increase in IL-6), after
OLTT (i.e. decreases in IL-8, SAA, sICAM-1, increase in
IL-6) and after OG + LTT (i.e. decreases in IL-8, SAA,
thrombomodulin, increase in IL-6) (Figure 3). However,
when compared to the control challenge only a limited
number of statistically significant differences were ob-
served (Figure 3): after the OG + LTT challenge, in-
creases in sICAM-1 at 4 h (259 ng/mL for OG + LTT vs
239 ng/mL for control, p < 0.01,) sVCAM-1 at 1 h and
4 h (437 and 447 ng/mL for OG + LTT vs 421 and
412 ng/mL for control, p < 0.05 and p < 0.01 respectively),
CRP at 4 h (994 ng/mL for OG+ LTT vs 908 ng/mL for
control, p < 0.05), and SAA at 0.5 h and 1 h (1949 and
1969 ng/mL for OG+ LTT vs 1815 and 1785 ng/mL for
control, p < 0.01 and p < 0.05, respectively). Furthermore,
increases in TNF-α were observed after the OLTT chal-
lenge at 0.5 h and 1 h and after the OGTT challenge at
8 h. The statistical significance of these changes (except
for CRP) could also be confirmed by the analysis based
on repeated measurements. Nevertheless, it should be
noted that the increases in the plasma levels of these
markers were small. The significant differences were mostly
due to decreased levels after the water control and could
only be detected when the data were normalized to the
baseline levels.
Noteworthy are the observations that were not related
to the dietary challenges but to experimental factors such
as prolonged fasting and diurnal effects. For example, con-
sistent significant increases in circulating IL-6 levels, and
decreases in IL-8 and SAA levels were observed over
time after all three dietary challenges, notably also afterthe water control challenge when compared to baseline
(Figure 3). Between-challenge comparisons, however, did
not show any significant differences from the control chal-
lenge, except for the higher levels of SAA at 0.5 h and 1 h
after the OG + LTT challenge.
Oxylipins
Diverse oxylipins were measured, because these lipid
mediators are involved in inflammation and cellular
growth processes. In general, the different dietary chal-
lenges induced statistically significant effects on the pre-
cursor oxylipins AA, LA, DHA and EPA and on a few
downstream oxylipin metabolites including the deriva-
tives of LA [9(S)-HODE, 13(S)-HODE, 9,10-DiHOME],
AA [5(S)-HETE, 15(S)-HETE,11,12-DiHETrE, 14,15-DiHE-
TrE] and DHA [17(S)-HDoHE, 17-keto-DHA, PGD2].
After the control challenge, significant increases in the pre-
cursors AA, DHA and EPA were observed after 8-10 h
when compared to baseline (Figure 4, Additional file 1:
Figure S2). Some derivatives of these precursors also
showed increased concentrations at 10 h, namely the AA-
derived oxylipins involved in the LOX pathway [5(S)-
HETE, 12(S)-HETE and 15(S)-HETE], in the CYP pathways
[11,12-DiHETrE, 14,15-DiHETrE], and the DHA-derived
oxylipins [17-(S)-HDoHE and 17keto-DHA]. The concen-
trations of some AA-derived oxylipins were significantly in-
creased at multiple time points, such as 12(S)-HETE (2, 6
and 10 h) and 5(S)-HETE (6 and 10 h). In comparison to
AA and DHA, the precursor LA only tended to be in-
creased, while its derivatives, namely 9(S)-HODE, 13(S)-
HODE were significantly increased after 10 h.
After the OGTT challenge, the precursor free fatty acids
AA, LA, DHA and EPA were significantly reduced after 2 h
when compared to baseline and to control challenge.
The concentrations reached control levels after 4 h. The
oxylipin derivatives of LA [9(S)-HODE, 13(S)-HODE, 9,10-
DiHOME], AA [5(S)-HETE, 15(S)-HETE, 11,12-DiHETrE,
14,15-DiHETrE] and DHA [17-HDoHE, 17-keto DHA]
showed similar curves as their precursors LA, AA and
DHA, respectively (Figure 4, Additional file 1: Figure S2).
The PGD2 response curve differed from its precursor
AA: reduced concentrations were observed over the
whole time course. The difference from the control
values was statistically significant based on repeated
measurements.
After the OLTT challenge, the precursors AA, EPA
and DHA were reduced over the whole time course with
the lowest concentrations at 2 h when compared to the
control challenge (Figure 4, Additional file 1: Figure S2).
The reductions at 2 h challenge was about 1/3 less than
those induced by the OGTT challenge. Interestingly, we
observed significant reductions in the derivatives of LA
[9(S)-HODE, 13(S)-HODE, 9,10-DiHOME] between 2–
8 h while the precursor itself only tended to be
Figure 3 Effect on inflammatory markers. Mean ± SEM postprandial relative CRP, IFNγ, IL-10, IL-12p70, IL-1β, IL-6, IL-8, SAA, sICAM-1, sVCAM-1,
TNF-α in healthy subjects (N = 14) after ingestion of water (□), OGTT (◊), OLTT (△), OG + LTT (○). ANOVA: OGTT, OLTT, OL + GTT versus water:
green p < 0.05, yellow p < 0.01, orange p < 0.001; water versus baseline; * p < 0.05, ** p < 0.01, *** p < 0.001.
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HETE] were reduced over the whole time course similar
to its precursor AA when compared to the control chal-
lenge. Yet, these reductions were less pronounced when
compared to the LA derivatives. In contrast to thesemetabolites involved in the LOX pathway, the CYP-
derived oxylipins [11,12-DiHETrE and 14,15-DiHETRrE]
were significantly increased at 2–6 h when compared to
control and thus showed an opposite response when
compared to their precursor AA.
Figure 4 Effect on oyxlipins. Mean ± SEM postprandial relative AA, 5(S)-HETE, 15(S)-HETE,11,12-DiHETrE, 14,15-DiHETrE, LA, 9(S)-HODE, 13(S)-
HODE, 9,10-DiHOME in healthy subjects (N = 12) after ingestion of water (□), OGTT (◊), OLTT (△), OG + LTT (○). ANOVA: OGTT, OLTT, OL + GTT
versus water: green p < 0.05, yellow p < 0.01, orange p < 0.001; water versus baseline; * p < 0.05, ** p < 0.01, *** p < 0.001.
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cursors AA, LA, DHA and EPA were observed between
2–8 h (Figure 4, Additional file 1: Figure S2). These
concentrations were also the lowest at 2 h, yet slightly
higher when compared to the OGTT challenge. The
control levels were still not reached at 10 h similar to
the OLTT challenge. Only LA showed a fast return
(within 2 h) to control levels. The response curves of
the oxylipin derivatives may be considered as superposi-
tions of their response curves after the OGTT and
OLTT challenges. The concentrations of the LA deriva-
tives [9(S)-HODE, 13(S)-HODE, 9,10-DiHOME] and
AA derivatives [5(S)-HETE, 15(S)-HETE] were reduced
at most time points with the lowest concentrations at2 h. The reductions were stronger (based on AUC
values) when compared to the OGTT and OLTT chal-
lenges alone. Furthermore, the concentrations of the
AA-derived 11,12-DiHETrE and 14,15-DiHETrE were
increased at 4–6 h. However, these increases were de-
layed and less strong when compared to the OLTT
challenge.Gene expression
The effect of different dietary challenges on the RNA
transcription in white blood cells was investigated for a
selection of genes. The results of the different challenge
tests were analyzed against different gene-sets that were
Table 2 Results of gene expression data
Genes significantly changed in the control challenge compared to baseline
# Name Symbol GeneID 0vs2 h 0vs6 h p
1 ABCA1 ABCA1 19 1,33 1,40 0.001
2 FLaP ALOX5AP 241 1,38 1,12 0.023
3 CXCR2 = IL-8RB CXCR2 3579 1,26 1,09 0.042
4 IL1RA IL1RN 3557 1,19 1,17 0.009
5 NLRP3 NLRP3 114548 1,12 1,08 0.011
6 PPARG PPARG 5468 −1,33 −1,11 0.004
7 PTX3 PTX3 5806 −1,37 −1,50 0.013
8 TLR2 (LPS) TLR2 7097 −1,13 −1,21 0.030
9 TNF-α TNF 7124 1,18 1,18 0.025
10 CCR6 CCR6 1235 1,02 1,23 0.017
11 DUSP2 DUSP2 1844 −1,64 −1,55 0.006
12 FPR2/ALX FFRA1 2358 1,05 −1,02 0.041
13 ERK MAPK1 5594 1,11 1,05 0.022
Genes significantly changed in OGTT compared to control challenge
# Name Symbol GeneId p OGTT Control
0vs2 h 0vs6 h 0vs2 h 0vs6 h
1 CXCR3 CXCR3 2833 0.009 1,11 −1,07 −1,04 1,23
2 IL10RA IL10RA 3587 0.016 −1,14 −1,26 −1,12 −1,06
3 INSIG1 (insulin induced gene 1) INSIG1 3638 0.031 −1,02 −1,06 −1,04 1,01
4 pyruvate dehydrogenase kinase 4 PDK4 5166 0.009 −3,11 1,66 1,11 1,37
5 ITGB1 ITGB1 3688 0.047 −1,09 −1,10 −1,06 1,09
6 lipocalin-2 LCN2 3934 0.0002 −1,07 −1,29 1,10 1,03
7 carnitine-acylcarnitine translocase SLC25A20 788 0.031 −1.31 1,26 1,08 1,11
Genes significantly changed in OLTT compared to control challenge
# Name Symbol GeneId p OLTT Control
0vs2 h 0vs6 h 0vs2 h 0vs6 h
1 acyl-Coenzyme A dehydrogenase ACADVL 37 0.029 −1,18 1,37 1,01 1,12
2 CYP4F3 CYP4F3 4051 0.012 1,11 1,20 1,14 1,12
3 ERK MAPK1 5594 0.035 −1,08 −1,09 1,11 1,05
Genes significantly changed in OG + LTT compared to control challenge
# Name Symbol GeneId p OG + LTT Control
0vs2 h 0vs6 h 0vs2 h 0vs6 h
1 CCR2 CCR2 729230 0.021 1,02 −1,09 −1,11 −1,02
2 Mgl CD301 CLEC10A 10462 0.002 −1,17 −1,01 −1,09 1,18
3 ITGAL CD11a ITGAL 3683 0.041 −1,10 −1,10 1,02 1,05
5 IL-18 IL18 3606 0.029 −1,01 1,12 −1,18 −1,14
6 CD162 - P-selectin ligand SELPLG 6404 0.027 1,05 −1,09 1,07 −1,05
7 carnitine-acylcarnitine translocase SLC25A20 788 0.041 1,08 1,11 −1,25 1,22
Significance is based on repeated measurements.
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Materials and Methods.
Overall, minor gene expression changes were observed
upon the different dietary challenges (Additional file 1:Table S5). The water control challenge showed differential
gene expression in 13 out of the 85 quantified genes (=15%
of genes) (Table 2). Both reduced and increased changes
were observed, which were in general below 1.5 fold
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were small. The 13 genes were scattered on the different
dedicated gene sets such as “PPAR signaling” (4 out of 11),
“lipid metabolism related to molecular transport” (3 out
of 11), “IL-6 signaling” (3 out of 15) and “IL-10 signaling”
(3 out of 17).
Seven, three and seven genes responded differently
to the OGTT, OLTT and OG + LTT challenges, respect-
ively, when compared to the control challenge (Table 2).
These genes did not cluster to specific pathways or bio-
logical functions. The strongest effect was found for the
gene PDK4 in response to OGTT, which showed a
3-fold decrease at 2 h. Moreover, a significant reduction
in IL10RA, a gene that is involved in IL-10 signaling,
was found at 6 h after the OGTT challenge. Note that
the effect in MAPK after OLTT could be due to differ-
ences in baseline values.
Interestingly, despite the significant changes observed
for the oxylipin metabolites, only one gene related to
oxylipin metabolism, namely CYP2J2, was marginally
changed after the OLTT challenge. Other genes encod-
ing enzymes involved in oxylipin metabolism, such as
ALOX5, ALOX12, ALOX15 and CYP4F3 were not af-
fected after the dietary challenges.
Discussion
The goal of this study was to select a challenge model
that would allow to study and quantify inflammatory re-
silience, i.e. the inflammatory stress response after a
dietary challenge. Therefore, we assessed the kinetic re-
sponse of three different dietary challenges and a water
control challenge on various markers related to inflam-
mation and metabolic control in 14 healthy males and
females.
Effect on inflammation
None of the dietary challenges induced a well-defined acute
inflammatory response when compared to the water con-
trol challenge as evidenced by multiple markers directly re-
lated to inflammation such as cytokines, vascular markers,
CRP, specific oxylipins and genes. Only modest, yet sta-
tistically significant increases in leukocytes, sVCAM-1,
sICAM-1, SAA and CRP were observed at certain time
points after the OG+ LTT challenge. Furthermore, subtle
and scattered increases in leukocyte numbers and TNF-α
were found after the OGTTchallenge.
The increase in leucocytes are suggestive for a modest
inflammatory response and in agreement with a number
of studies showing comparable small increases in leu-
kocyte numbers compared to baseline after dietary chal-
lenge [12,14,26-29]. However, only studies by van
Oostrom et al. included a water control and showed
that, next to a generic time-dependent increase in lym-
phocytes, the increases in leukocytes after lipid, glucoseand combined challenges were challenge specific and
mostly due to an increase in neutrophils [12,14,29]. To-
gether with our observations, these results are the only
firm evidence suggesting that the inflammatory response
can be attributed to the dietary challenges and not to
other experimental conditions. Yet it is notable, that our
observations are less convincing than those by van Oos-
trom et al., because we only found a significant increase
in WBC compared to the water control challenge at 1–2
time points after the OGTT and OG + LTT challenges
but not after OLTT alone. It remains unclear why the
studies from van Oostrom et al. showed clearer effects.
In this study, none of the cytokines and acute-phase
proteins were consistently affected by the dietary chal-
lenges. Other similar studies in healthy subjects have
shown ambiguous results on CRP, TNF-αlpha and IL-6.
For example, increases in TNF-α have been reported after
high fat loads [15,23], whereas others studies did not find
this effect [17,27]. Moreover, increases in postprandial
CRP have been reported after OGTT [30] and OLTT [15]
challenges, whereas other studies did not observe signifi-
cant differences in CRP after a high fat challenge
[17,27,31]. These different observations are not readily ex-
plained by e.g. differences in study population, caloric load
or composition of challenges. However, it is noticeable
that Derosa et al. have demonstrated significant increases
in these markers in a much larger population [15,30].
Metabolites mostly indicative of inflammatory processes
such as the AA-derived oxylipins involved in the COX
pathway [prostaglandins (e.g. PGF2α, PGD2, PGE2) and
thromboxanes (e.g. TXB2)] did not show significant effects
after the dietary challenges, except for the marginal reduc-
tion in PGD2 after the OGTTchallenge. Moreover, none of
the gene-sets mostly indicative of pro-inflammatory re-
sponse [‘lipid metabolism related to inflammatory response’,
‘inflammatory response related to infectious disease’, and
‘IL-6 signaling’] or belonging to anti-inflammatory response
[‘Il-10 signaling’] were significantly regulated by one of the
dietary challenges. This is in line with another study, show-
ing no effects on the gene expressions of TNF-α, IL-8 and
Nfκb1 upon a high-fat challenge high in saturated fat [32].
Effect on vascular inflammation
From the three dietary challenges tested in this study, only
the OG+ LTT challenge induced subtle increases in vari-
ous vascular inflammatory markers, such as sVCAM-1 and
sICAM-1. Effects on sVCAM-1 and sICAM-1 after dietary
challenges in healthy subjects are inconsistent, as some
studies have reported a significant increase in these
markers [8,15,30] in contrast to others that have found no
increases [22,33]. Since none of these studies have incorpo-
rated a non- or placebo-challenged control group, these
observations need to be confirmed in well-controlled stud-
ies. The increase in plasma sICAM-1 and sVCAM-1 levels
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trol as observed in our study has limited value, because the
increase was small and partly due to a decrease in the
water control. In addition, no between-challenge effects
were observed on the other vascular markers, namely
sICAM-3, E-selectin, P-selectin, thrombomodulin, leading
us to the conclusion that the impact of the dietary chal-
lenges on vascular markers of inflammation was limited in
this study.
Our results on the oxylipins that are involved in the
LOX and CYP pathways may further support the role of
endothelial inflammation and vascular functions consid-
ering that these metabolites can be incorporated into
membranes within vascular tissues in contrast to COX-
derived metabolites [34]. It has been suggested that the
CYP-derived DiHETrE’s, which were down-regulated
after the OGTT challenge and up-regulated after OLTT
and OG + LTT challenges in the current study, may be
released from the vascular endothelium and lead to vaso-
dilation and vascular smooth-muscle relaxation via stimu-
lation of Ca2+-activated K+ channels in coronary arteries or
via modulation of endothelial NO release [35]. Further-
more, it has been found that the LOX-derived 9-HODE
and 13-HODE, which were reduced after all three dietary
challenges, can be released by lipoprotein lipase on the
endothelium and lead to increased expression of TNF-α,
vascular cell adhesion molecule (VCAM) and E-selectin
and thus to impaired endothelium-dependent vasodilation
[34,36]. 13(S)-HODE has also been reported to inhibit
platelet binding to endothelial cells [37] and to have anti-
proliferative activity [38].
Effect on metabolic control
All three dietary challenges clearly induced changes re-
lated to metabolic control. In the post-absorptive state,
the intake of dietary glucose usually leads to increased
serum insulin concentrations followed by reduced lipoly-
sis which is reflected by reductions in free fatty acids
(FFA’s) and glycerol concentrations. This explains the
consistent reductions of the precursor free fatty acids
AA, LA, EPA and DHA 2 h after the OGTT and OL +
GTT challenges. As soon as glucose and insulin reach
baseline levels, fatty acids from peripheral tissues are re-
leased into circulation, as shown by the increase in the
precursor oxylipins.
The response curves of the downstream oxylipins after
the OGTT challenge were similar to the responses of
their precursor free fatty acids suggesting that the regu-
lation of these metabolites relate to insulin signaling. In
contrast, after the OLTT challenge, only the CYP epoxy-
genase products, 11,12-DiHETrE and 14,15-DiHETrE
were up-regulated, while the others [e.g. 9(S)-HODE, 13
(S)-HODE, 9,10-DiHOME] were down-regulated indi-
cating specific regulation of eicosanoid pathways by thischallenge model. The changes of the AA-derived metab-
olites [DiHETrE’s] may be related to the activity of
PPAR’s considering that these transcriptional regulators
of lipid and carbohydrate metabolism can be activated
by saturated and unsaturated long-chain fatty acids and
their eicosanoid (AA) derivatives [39]. The PPAR activa-
tion may further modulate the inflammatory response in
different immunological and vascular wall cell types
[40]. In contrast to the increases in 11,12-DiHETrE and
14,15-DiHETrE after the OLTT challenge, another study
including a 4-week treatment with ω-3 fatty acids has re-
sulted in reductions in the AA-derived metabolites
DiHETrE’s and increases in EPA- and DHA-derived me-
tabolites involved in the CYP pathway [41]. These dif-
ferences may account for the anti-inflammatory and
pro-resolution effects of ω-3 fatty acids (EPA, DHA) as
opposed to the high load of saturated fatty acids with
pro-inflammatory properties [6]. They may also reflect a
fine balance between EPA, DHA and AA competing for
the conversion by CYP enzymes [42].
Effects that cannot be attributed to the dietary challenges
The inclusion of the water control challenge was crucial to
account for factors that were not related to the dietary
challenge, such as diurnal variations, prolonged fasting and
sample procedure. For example, the gradually decreased
concentrations of glucose, insulin and triglycerides and the
increased concentrations of several oxylipins observed dur-
ing the control challenge can be attributed to prolonged
fasting. Furthermore, in contrast to widely reported in-
creases in postprandial IL-6 [7,15,17,18,22,27,29,43,44], we
observed a similar increase in IL-6 concentrations in all
dietary and the water control challenges suggesting that
the effect was not related to the dietary challenges, but ra-
ther to local tissue production associated with cannula
placement. It has been described that venous cannulation
for more than 3 hours may lead to local tissue production
of IL-6 [45-47] and thus hamper accurate detection of sys-
temic IL-6. Interestingly, all studies that have reported ef-
fects on IL-6 after dietary challenges used a continuous
intravenous line [7,15,17,18,22,27,29,43,44]. Studies that
have seen no effects or even decreases in postprandial IL-6
levels either used venapuncture [31] or have not reported
the method used for blood sampling [33,48,49]. This sug-
gests that the increase in plasma IL-6 levels may be related
to the blood sampling method. Alternatively, the increase
in IL-6 may be explained by diurnal variation [50,51], a
conclusion also drawn by van Oostrom et al. [29] and
Tulk et al. [18].
Conclusions
Overall, our results together with evidence from literature
indicate that the subtle increase in circulating leukocytes
seems the most consistent effect of an inflammatory
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changes in cytokine levels that have been observed in some
other studies are overall far less consistent and not sup-
ported by our data. Moreover, the subtle increases in vas-
cular markers such as sICAM-1 and sVCAM-1 after the
OG+ LTT challenge are of limited value, because they only
became apparent in comparison to the water control chal-
lenge which has proved to be essential to control for fac-
tors such as diurnal variation, prolonged fasting, and
sampling procedure.
It is worth mentioning, that these marginal effects
were observed in healthy subjects and after the con-
sumption of a single dose of high fat and/or glucose. It
remains to be investigated, whether the threshold for in-
flammation can be shifted in compromised/diseased
population or by sustained dietary intake. In addition,
the number of subjects enrolled in this study was low
and thus increasing the sample size may translate into
higher statistical significance. As alternative to dietary
challenges, low-dose lipopolysaccharide (LPS) challenges
have been described in literature to elicit time-resolved
measurable acute inflammatory responses and thus may
be a more appropriate challenge model of low-grade in-
flammation [52].
Interestingly, all dietary challenges clearly induced
changes in several oxylipins that were related to meta-
bolic control and possibly to vascular functions. How-
ever, the meaning of these changes often is not clear
because of insufficient knowledge on the functions of
specific oxylipins. Further studies are required to eluci-
date the role of oxylipins in metabolic and inflammatory
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